Pay in 4 interest-free payments of $7.40 Learn more
Ships within 48 hours · Estimated delivery Oct 18 - Oct 23
Bremelanotide: First Approval
Prior authorization requirements are common among commercial payers for ongoing injection therapy, so verify coverage and authorization requirements with each plan before initiating therapy for private-pay patients
Weekly injections, daily pills, custom compounding schedules every major GLP-1 medication, each tracked on its own rhythm
Currently, VK2809 has progressed to phase 2 clinical trial in patients with primary hypercholesterolemia and NAFLD (ClinicalTrials.gov identifier: NCT04173065)
IV therapy works wonders for hangovers by tackling the three main culprits: dehydration, nutrient depletion, and inflammation
US$ 20.45
US$ 24.17
US$ 25.97
US$ 20.65
US$ 28.00
US$ 22.79
US$ 21.63
US$ 27.81
US$ 21.40
